Evaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 Cream
Status:
Completed
Trial end date:
2019-04-05
Target enrollment:
Participant gender:
Summary
This trial is a 6-week, Randomized study evaluating the potential of MC2-01 Cream to induce a
photoallergic skin reaction in Healthy subjects, using a controlled photopatch test design.
Phase:
Phase 1
Details
Lead Sponsor:
Drug Delivery Solutions Ltd. (part of MC2 Therapeutics) MC2 Therapeutics